MD MEDNAX Inc.

MEDNAX Announces Divisional Leadership Changes

MEDNAX, Inc. (NYSE:MD), today announced that Karl Wagner, President of the Company’s Eastern Division, has indicated his intent to resign from the company, in order to pursue personal opportunities. Mr. Wagner, who joined MEDNAX in 1997 and previously served as the Company’s Treasurer, Chief Financial Officer and President of MEDNAX’s American Anesthesiology Division, will remain in his full-time position through early 2017 and serve on a consulting basis through the first half of 2017.

“I want to thank Karl for all the contributions he has made to MEDNAX over the last nineteen years,” said Roger J. Medel, M.D., Chief Executive Officer of MEDNAX. “In the financial and operating roles he has played, Karl has been an integral part of the growth, strategic evolution, and success we have achieved as an organization.”

“After nineteen years at MEDNAX, I have decided that the time is right to take a step back and determine the next opportunity to pursue,” said Mr. Wagner. “I have the highest confidence in the ability of my associates and friends at MEDNAX to execute on the strategy we have undertaken. I also believe the Company’s focus on improving the care of our patients while bringing solutions to our partners is exactly the right plan. I will always take with me the wonderful stories of how we have impacted an untold number of families both from the contributions of the organization as a whole or the individual care provided by our clinicians.”

Separately, David Clark, President of MEDNAX’s Western Division, has been named President, MEDNAX Physician Services, which encompasses leadership of the Company’s Clinical Services, Eastern and Western Divisions. Mr. Clark joined MEDNAX in 2001 and served as Chief Operating Officer of the Company’s Pediatrix Division from 2008 until 2015. He served as Senior Vice President, Operations, from 2003 to 2008 and as Vice President, Operations, South Central Region, from 2001 to 2003.

ABOUT MEDNAX

MEDNAX, Inc. is a national health solutions partner comprised of the nation's leading providers of physician services. Physicians and advanced practitioners practicing as part of MEDNAX are reshaping the delivery of care within their specialties and subspecialties, using evidence-based tools, continuous quality initiatives, clinical research and telemedicine to enhance patient outcomes and provide high-quality, cost-effective care. The Company was founded in 1979, and today, through its affiliated professional corporations, MEDNAX provides services through a network of more than 3,600 physicians in all 50 states and Puerto Rico. In addition to its national physician network, MEDNAX provides services to healthcare facilities and physicians in over 40 states through two complementary businesses, consisting of a revenue cycle management company and a consulting services company. Additional information is available at www.mednax.com.

EN
07/11/2016

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on MEDNAX Inc.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Pediatrix Medical Group Inc.: 1 director

A director at Pediatrix Medical Group Inc. sold 27,600 shares at 15.350USD and the significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Mednax, Inc.: Covenant Quality Post-Sale Snapshot: $400m 5.375% Senior...

Mednax. Inc.’s covenant package provides lower-tier HY-Lite protection, reflecting a covenant quality score of 5.00.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch